Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Sarah Walker

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|June 27, 2015
Contribution of behavioural science to antibiotic stewardshipSarah Tonkin-Crine, Ann Sarah Walker, Chris C Butler
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
DOOR/RADAR: A Gateway Into the Unknown?Patrick Peter John Phillips, Tim Peter Morris, Ann Sarah Walker
BMJ Open|July 18, 2025
Comparing thermal imaging and non-contact infrared thermometers for monitoring skin temperature in a prospective cohort with lower limb cellulitisElizabeth L A Cross, Martin John Llewelyn, Ann Sarah Walker, et al.
Annals of Neurology|September 27, 2007
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapyKrishnan Bhaskaran, Cristina Mussini, Andrea Antinori, et al.
BMJ (Clinical Research Ed.)|March 1, 2019
Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelinesKoen B Pouwels, Susan Hopkins, Martin J Llewelyn, et al.
Pharmacoepidemiology and Drug Safety|December 3, 2024
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 TrialMichael Schomaker, Paolo Denti, Andrzej Bienczak, et al.
Trials|February 9, 2025
Safety reporting in neonatal clinical trials: reflections towards optimal, globally relevant approachesLouise F Hill, Christina W Obiero, Adrie Bekker, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 24, 2025
Case ascertainment of a potential centrally-implemented, automated system for national surveillance of healthcare-associated infections, England, 2016 to 2023Jack Cregan, Olisaeloka Nsonwu, Dimple Chudasama, et al.
BMJ Medicine|April 17, 2023
Inequalities in SARS-CoV-2 case rates by ethnicity, religion, measures of socioeconomic position, English proficiency, and self-reported disability: cohort study of 39 million people in England during the alpha and delta wavesTim Larsen, Matthew L Bosworth, Daniel Ayoubkhani, et al.
The Lancet. Microbe|August 2, 2025
SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance studyMahan Ghafari, Steven A Kemp, Matthew Hall, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|June 27, 2015
Contribution of behavioural science to antibiotic stewardshipSarah Tonkin-Crine, Ann Sarah Walker, Chris C Butler
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2015
DOOR/RADAR: A Gateway Into the Unknown?Patrick Peter John Phillips, Tim Peter Morris, Ann Sarah Walker
BMJ Open|July 18, 2025
Comparing thermal imaging and non-contact infrared thermometers for monitoring skin temperature in a prospective cohort with lower limb cellulitisElizabeth L A Cross, Martin John Llewelyn, Ann Sarah Walker, et al.
Annals of Neurology|September 27, 2007
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapyKrishnan Bhaskaran, Cristina Mussini, Andrea Antinori, et al.
BMJ (Clinical Research Ed.)|March 1, 2019
Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelinesKoen B Pouwels, Susan Hopkins, Martin J Llewelyn, et al.
Pharmacoepidemiology and Drug Safety|December 3, 2024
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 TrialMichael Schomaker, Paolo Denti, Andrzej Bienczak, et al.
Trials|February 9, 2025
Safety reporting in neonatal clinical trials: reflections towards optimal, globally relevant approachesLouise F Hill, Christina W Obiero, Adrie Bekker, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 24, 2025
Case ascertainment of a potential centrally-implemented, automated system for national surveillance of healthcare-associated infections, England, 2016 to 2023Jack Cregan, Olisaeloka Nsonwu, Dimple Chudasama, et al.
BMJ Medicine|April 17, 2023
Inequalities in SARS-CoV-2 case rates by ethnicity, religion, measures of socioeconomic position, English proficiency, and self-reported disability: cohort study of 39 million people in England during the alpha and delta wavesTim Larsen, Matthew L Bosworth, Daniel Ayoubkhani, et al.
The Lancet. Microbe|August 2, 2025
SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance studyMahan Ghafari, Steven A Kemp, Matthew Hall, et al.
Pageof 6